Precision Neuroscience
New York, US · Founded 2020 · Delaware corporation · 6 known investors
Founders & leadership
Precision Neuroscience was founded in 2020 by Benjamin Rapoport and Michael Mager.
BR
Benjamin RapoportPresident, Chief Science Officer
MM
Michael MagerChief Executive Officer
CM
Craig MermelPresident and Chief Product Officer
MK
MIchael KaswanChief Financial Officer
Board
EM
Eric M. AttiasBoard director
HM
Howard Morganin𝕏Board directorEarly-internet and database researcher; founding Renaissance president; Idealab investor; First Round co-founder; B Capital chair
RM
JC
Jason ChenBoard director
Investors · 6
.jpeg){kind=logo}
Reported raises · per SEC filings
Form D private placements$172.3M disclosed across 4 rounds · 2021–2024
▶$93.1MraisedOct 2024 · 21 investors · Other Health CareRule 506(b)
▶$93.1MraisedOct 2024 · 21 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Eric M. AttiasDirector
- Craig MermelDirector, Executive Officer
- Howard MorganDirector
- MIchael KaswanExecutive Officer
- Benjamin RapoportDirector, Executive Officer
- Ravi MehtaDirector
- Jason ChenDirector
- Michael MagerDirector, Executive Officer
- Offering amount
- $150M
- Amount sold
- $93.1M
- First sale
- Oct 2024
- Incorporated
- Corporation, Delaware, 2020
- Federal exemptions
- 06b
▶$27.5MraisedApr 2024 · 5 investors · Other Health CareRule 506(b)
▶$27.5MraisedApr 2024 · 5 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Mike KaswanExecutive Officer
- Benjamin RapoportDirector, Executive Officer
- Michael MagerDirector, Executive Officer
- Jason ChenDirector
- Craig MermelDirector, Executive Officer
- Howard MorganDirector
- Eric M. AttiasDirector
- Ravi MehtaDirector
- Offering amount
- $45M
- Amount sold
- $27.5M
- First sale
- Mar 2024
- Incorporated
- Corporation, Delaware, 2020
- Federal exemptions
- 06b
▶$41.2MraisedFeb 2023 · 20 investors · Other Health CareRule 506(b)
▶$41.2MraisedFeb 2023 · 20 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Benjamin RapoportExecutive Officer, Director
- Ravi MehtaDirector
- Eric M. AttiasDirector
- Jason ChenDirector
- Howard MorganDirector
- Craig MermelExecutive Officer, Director
- Michael MagerExecutive Officer, Director
- Offering amount
- $42M
- Amount sold
- $41.2M
- First sale
- Dec 2022
- Incorporated
- Corporation, Delaware, 2020
- Federal exemptions
- 06b
▶$10.5MraisedApr 2021 · 2 investors · Other Health CareRule 506(b)
▶$10.5MraisedApr 2021 · 2 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Benjamin RapoportExecutive Officer, Director
- Craig MermelDirector
- Michael MagerExecutive Officer, Director
- Offering amount
- $12M
- Amount sold
- $10.5M
- First sale
- Apr 2021
- Incorporated
- Corporation, Delaware, 2021
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Legal entities · 1
corporate structurePrecision NeuroscienceDelaware
In the news
Frequently asked questions
- Who founded Precision Neuroscience?
- Precision Neuroscience was founded by Benjamin Rapoport, Michael Mager in 2020.
- Who are Precision Neuroscience's investors?
- Precision Neuroscience's investors include Alumni Ventures, B Capital Group, Basecamp Fund, SCI Ventures, Forepont Capital Partners, Steadview Capital.
- How much funding has Precision Neuroscience raised?
- Precision Neuroscience has disclosed $172.3M raised across 4 rounds.
- Where is Precision Neuroscience headquartered?
- Precision Neuroscience is headquartered in New York, US.